Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 5.1 Opinion of Winston & Strawn LLP
- 23.1 Consent of Friedman LLP, Independent Registered Public Accounting Firm to Estrella Biopharma, Inc
- 23.2 Consent of Marcum LLP, Independent Registered Public Accounting Firm to Estrella Biopharma, Inc
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 15 May 24 424B3 Prospectus supplement
- 8 Mar 24 424B3 Prospectus supplement
- 7 Mar 24 424B3 Prospectus supplement
- 15 Feb 24 424B3 Prospectus supplement
- 12 Feb 24 424B3 Prospectus supplement
- 29 Dec 23 EFFECT Notice of effectiveness
- 28 Dec 23 424B3 Prospectus supplement
- 15 Dec 23 S-1/A IPO registration (amended)
- 13 Nov 23 S-1/A IPO registration (amended)
-
10 Oct 23 S-1 IPO registration
ESLA similar filings
Filing view
External links
Exhibit 23.2
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Estrella Immunopharma, Inc. on Form S-1 of our report dated October 5, 2023 with respect to our audit of the financial statements of Estrella Biopharma, Inc. as of June 30, 2023 and for the year ended June 30, 2023, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
Costa Mesa, CA
October 9, 2023